Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,040 INR | -0.31% | -1.27% | -19.39% |
Apr. 15 | Alkyl Amines Chemicals Board to Consider Final Dividend for Fiscal 2024 | MT |
Mar. 18 | Alkyl Amines Chemicals Limited Approves Board Appointments | CI |
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 73.85 times its estimated earnings per share for the ongoing year.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 506767 Stock
- ALKYLAMINE Stock
- Ratings ALKL AMIN